| Application # | Type | Sponsor | Notes | Product # | Drug Name | Form | Strength | Active Ingredient | Approval Date | Marketing Status | Reference Standard |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 217171 | NDA | APELLIS PHARMS | 001 | SYFOVRE | SOLUTION;INTRAVITREAL | 15MG/0.1ML (15MG/0.1ML) | PEGCETACOPLAN | 2023-02-17 | Prescription | Yes | |
| 215014 | NDA | APELLIS PHARMS | 001 | EMPAVELI | SOLUTION;SUBCUTANEOUS | 1080MG/20ML (54MG/ML) | PEGCETACOPLAN | 2021-05-14 | Prescription | Yes |